We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+9.47%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$180B
AUM Growth
+$20.4B
Cap. Flow
+$6.1B
Cap. Flow %
3.39%
Top 10 Hldgs %
26.13%
Holding
7,254
New
260
Increased
3,541
Reduced
2,314
Closed
700

Sector Composition

Rank Sector Weight
1 Technology 8.85%
2 Healthcare 5.77%
3 Financials 5.26%
4 Consumer Discretionary 4.71%
5 Communication Services 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEPT
6826
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
-96
Closed -$477K
BFX
6827
DELISTED
BowFlex Inc.
BFX
$0 ﹤0.01%
21
-44,261
-100% -$69K
FGH
6828
DELISTED
FG Group Holdings Inc.
FGH
$0 ﹤0.01%
3
-179
-98% -$505
MDRX
6829
CALL
DELISTED
Veradigm Inc. Common Stock
MDRX
-19,100
Closed -$210K
SIEN
6830
PUT
DELISTED
Sientra, Inc.
SIEN
-8,070
Closed -$523K
DMK
6831
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
-2
Closed
WTER
6832
DELISTED
The Alkaline Water Company Inc. Common Stock
WTER
$0 ﹤0.01%
+1
New +$20
ARAV
6833
DELISTED
Aravive, Inc. Common Stock
ARAV
$0 ﹤0.01%
1
-38
-97% -$336
MRTX
6834
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-45,000
Closed -$3.51M
ONCT
6835
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
-1
Closed
PATI
6836
DELISTED
Patriot Transportation Holding, Inc. Common Stock
PATI
$0 ﹤0.01%
9
+8
+800% +$146
FTCH
6837
CALL
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
-61,100
Closed -$528K
PCTI
6838
DELISTED
PCTEL, Inc. Common Stock
PCTI
$0 ﹤0.01%
1
-10
-91% -$83
AAIC
6839
DELISTED
Arlington Asset Investment Corp.
AAIC
-18,378
Closed -$101K
CTG
6840
DELISTED
Computer Task Group, Inc.
CTG
-60
Closed
ARCE
6841
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
-91
Closed -$5K
APRN
6842
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
0
ZYNE
6843
CALL
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
-100
Closed -$1K
RETA
6844
CALL
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
-15,000
Closed -$1.2M
RETA
6845
PUT
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
-20,000
Closed -$1.61M
NEX
6846
DELISTED
NexTier Oilfield Solutions Inc.
NEX
-178,602
Closed -$1.08M
UBP
6847
DELISTED
Urstadt Biddle Properties Inc.
UBP
-76
Closed -$1K
MSVB
6848
DELISTED
Mid-Southern Bancorp, Inc.
MSVB
$0 ﹤0.01%
+1
New +$13
SAL
6849
DELISTED
Salisbury Bancorp, Inc.
SAL
-2
Closed
OFED
6850
DELISTED
Oconee Federal Financial Corp.
OFED
-36
Closed -$1K

Similar funds

Barclays's Q4 2019 Portfolio in Review

As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.

By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.

  • Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
  • Barclays added most to Apple in Q4 2019, an estimated $572M increase.
  • Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
  • Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
  • Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
  • Barclays opened 260 new positions and closed 700 in Q4 2019.
  • Barclays's portfolio value rose 13% quarter-over-quarter to $180B.

Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.